Mizuho cuts target for Alcon stock from USD 85 to USD 80
Published on 10/16/2026 at 09:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- Mizuho lowered its Alcon target from USD 85 to USD 80 on October 13, 2026.
- Second-quarter revenue reached USD 2.79 billion against USD 2.56 billion consensus.
- Alcon stock trades at EUR 59.24 at 9:15 a.m. CEST at Lang & Schwarz on October 16, 2026.
- Alcon is scheduled to report third-quarter results on November 10, 2026.
Mizuho lowered its Alcon target from USD 85 to USD 80 on October 13, 2026, while keeping an Outperform rating, according to Markets Insider. Alcon stock was trading at EUR 59.24 at Lang & Schwarz on October 16, 2026 at 9:15 a.m. CEST.
Why Mizuho cut the target
The target reduction came in a third-quarter earnings preview that cited expected procedure-volume headwinds linked to the Affordable Care Act and Medicaid contraction, the report said. The revised USD 80 target remains above the latest primary-market quotation of CHF 54.88 at SIX at 9:07 a.m. CEST on October 16, 2026.
That contrast leaves the next results as the key test of the analyst view. Alcon's second-quarter revenue was USD 2.79 billion, compared with USD 2.56 billion consensus, while adjusted earnings per share reached USD 0.84 against USD 0.80 consensus, a 5.00 percent beat, according to Business Quant.
Three events shape the setup
On August 10, 2026, Alcon reported second-quarter revenue of USD 2.79 billion, according to Business Quant. On October 5, 2026, the company announced demonstrations of its UNITY platform and other products at the American Academy of Ophthalmology meeting, with booth number 1519, according to Alcon.
On October 13, 2026, Mizuho cut its target from USD 85 to USD 80. The sequence combines product visibility with a nearer-term question about procedure volumes and quarterly execution.
What does the next quarter test?
Alcon is scheduled to report third-quarter results on November 10, 2026, according to Yahoo Finance. Business Quant lists consensus third-quarter revenue at USD 2.77 billion and earnings per share at USD 0.83, giving investors two concrete benchmarks after the second-quarter revenue and earnings-per-share beats.
Stock valuation and next date
Alcon's primary listing is on SIX, where its market capitalization stood at CHF 26.5 billion and its 52-week range was CHF 47.80 to CHF 68.34 in the latest structured quote. The Swiss quotation puts the company in a different currency frame from the euro indication used by German investors.
The next scheduled reporting date is November 10, 2026. The date matters because the current analyst debate centers on procedure volumes, while Alcon's recent product presentation highlights expansion across surgical and vision-care products.
Price stays in the foreground
Alcon stock was trading at EUR 59.24 at Lang & Schwarz on October 16, 2026 at 9:15 a.m. CEST. The primary-market quote was CHF 54.88 at SIX at 9:07 a.m. CEST, a separate Swiss-market reference. The further course of trading is shown by the continuously updated real-time quote of Alcon stock.
Alcon stock key data
- Company: Alcon Inc.
- ISIN: CH0432492467
- Ticker: ALC
- Primary exchange: SIX
- Price Lang & Schwarz (as of October 16, 2026, 9:15 a.m. CEST): EUR 59.24
- Market capitalization: CHF 26.5 billion (as of October 16, 2026)
- 52-week range: CHF 47.80-68.34 (as of October 16, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
- Index membership: SMI
- Next earnings date: November 10, 2026
Market context: Market report SMI.
